Literature DB >> 2839571

Changes in hepatic functional reserve after transcatheter embolization of hepatocellular carcinoma. Assessment by maximal removal rate of indocyanine green.

S Miyoshi1, Y Minami, S Kawata, Y Imai, R Saitoh, S Noda, S Tamura, S Tarui.   

Abstract

To clarify the influence of transcatheter arterial embolization (TAE) on hepatic function, the maximal removal rate of indocyanine green (ICG-Rmax), which represents the hepatic functional reserve, and the plasma disappearance rate of indocyanine green (k-ICG) were measured serially before and after 15 TAE procedures performed on 13 hepatocellular carcinoma (HCC) patients with underlying hepatic diseases. Compared to the values before TAE, ICG-Rmax values did not change or gradually decreased during 4 weeks in seven of the 13 patients but markedly decreased in the remaining six by as much as 50% during the first week. k-ICG values remained almost unchanged at any time after TAE. Albumin and prothrombin time were serially measured before and after 24 TAE procedures performed on 21 HCC patients with underlying hepatic diseases in whom no plasma products had been used for therapy. Albumin decreased by up to 75% in one of the 21 patients during the first week but did not change or gradually decreased in 20 of the 21 patients. Prothrombin time showed no obvious changes. This study showed that prominent changes occurred in ICG-Rmax, i.e., in the hepatic functional reserve, after TAE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839571     DOI: 10.1016/s0168-8278(88)80050-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  4 in total

1.  Percutaneous transsplenic embolization of esophageal and gastrio-fundal varices in 18 patients.

Authors:  G Q Gong; X L Wang; J H Wang; Z P Yan; J M Cheng; S Qian; Y Chen
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma.

Authors:  S Bianco; C Merkel; S Savastano; S Bellon; M Chiesura-Corona; M Bolognesi; D Miotto; E Enzo; G Feltrin; A Gatta
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

3.  Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Noboru Maeda; Keigo Osuga; Koji Mikami; Hiroki Higashihara; Hiromitsu Onishi; Yasuhiro Nakaya; Mitsuaki Tatsumi; Masatoshi Hori; Tonsok Kim; Kaname Tomoda; Hironobu Nakamura
Journal:  Radiat Med       Date:  2008-05-29

4.  The Safety and Clinical Outcomes of Chemoembolization in Child-Pugh Class C Patients with Hepatocellular Carcinomas.

Authors:  Tae Won Choi; Hyo-Cheol Kim; Jeong-Hoon Lee; Su Jong Yu; Beomsik Kang; Saebeom Hur; Myungsu Lee; Hwan Jun Jae; Jin Wook Chung
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.